Search Stock News and Analysis

SEARCH RESULTS FOR: "Tag: AXGT"

REFINE YOUR SEARCH

REFINE YOUR SEARCH:

ARTICLES/BLOGS

2019(4)

CATEGORIES

Analyst Update(3)

Buzz Stocks(1)

Intraday Option Activity(1)

Baird: Buy This Biotech Before Data Release

https://www.schaeffersresearch.com/content/news/2019/08/12/baird-buy-this-biotech-before-data-release

8/12/2019 2:59 PM

Axovant Gene Therapies Ltd (NASDAQ:AXGT) is getting a boost from Baird today -- bucking the broad-market trend lower -- after the analyst upgraded the biotech to "outperform" from "neutral," predicti...

Options Heat Up on "Undervalued" Drug Stock

https://www.schaeffersresearch.com/content/options/2019/06/21/options-heat-up-on-undervalued-drug-stock

6/21/2019 10:34 AM

The shares of Axovant Gene Therapies Ltd (NASDAQ:AXGT) are soaring today, thanks to some upbeat analyst attention. Specifically, SVB Leerink initiated coverage of AXGT stock with an "outperform" rati...

Jefferies Calls Bottom on Gene Therapy Stock After Huge Sell-Off

https://www.schaeffersresearch.com/content/news/2019/06/12/jefferies-calls-bottom-on-gene-therapy-stock-after-huge-sell-off

6/12/2019 10:30 AM

Axovant Sciences Ltd (NASDAQ:AXGT) has seen its stock fall from the mid-$30 range to yesterday's close of $3.94, even after positive data for its Parkinson's treatment. However, Jefferies referred to...

Penny Stock Pops on Parkinson's Treatment Progress

https://www.schaeffersresearch.com/content/news/2019/03/11/penny-stock-pops-on-parkinsons-treatment-progress

3/11/2019 9:43 AM

The shares of biotechnology concern Axovant Sciences Ltd (NASDAQ:AXGT) are up 54% at $2.28 in early trading after announcing successful phase 2 trial results for its Parkinson's treatment, AXO-Lenti...

PEOPLE ALSO SEARCH FOR

AXGT

Partner Center